[
    "{\"step_by_step_thinking\": \"The document [0] describes a pilot observational study where 18 inpatients with advanced disease and refractory breathlessness received opioid Patient-Controlled Therapy (PCT). The study found that the Numeric rating scale of current breathlessness decreased and physiological parameters were stable over time. On Day 3, 12/12 patients confirmed that this mode of application provided relief of breathlessness. Therefore, it can be concluded that opioid PCT is a feasible and acceptable therapeutic method to reduce refractory breathlessness in palliative care patients.\", \"answer_choice\": \"A\"}"
]